Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data
Revelation Biosciences (NASDAQ:REVB) has issued a reminder for their upcoming webcast and conference call scheduled for September 10th at 8:30 am Eastern Time. The event will discuss top-line data from their PRIME Phase 1b clinical trial.
Participants can join via webcast or dial in using the toll-free number 888-506-0062 (US) or +1 973-528-0011 (International) with access code 289672. The company has made available both the original data announcement and the presentation materials on their website.
Revelation Biosciences (NASDAQ:REVB) ricorda il webcast e la conference call in programma per il 10 settembre alle 8:30 (ET). Durante l'evento saranno discussi i dati principali dello studio clinico PRIME Phase 1b.
Per partecipare 猫 possibile seguire il webcast o chiamare il numero verde 888-506-0062 (USA) oppure +1 973-528-0011 (internazionale) con il codice d'accesso 289672. Sul sito dell'azienda sono disponibili l'annuncio dei dati e le slide della presentazione.
Revelation Biosciences (NASDAQ:REVB) recuerda su webcast y conference call programados para el 10 de septiembre a las 8:30 am hora del Este. El evento tratar谩 los datos principales del ensayo cl铆nico PRIME Phase 1b.
Los participantes pueden unirse v铆a webcast o marcando el n煤mero gratuito 888-506-0062 (EE.聽UU.) o +1 973-528-0011 (internacional) con el c贸digo de acceso 289672. En la web de la compa帽铆a est谩n disponibles el comunicado de datos original y el material de la presentaci贸n.
Revelation Biosciences (NASDAQ:REVB)电� 霃欕秬 鞁滉皠 旮办 9鞗� 10鞚� 鞓れ爠 8:30鞐� 鞓堨爼霅� 鞗箘旌愳姢韸� 氚� 旎嵓霟办姢 旖滌潉 鞛晥雮错暕雼堧嫟. 鞚措矆 頄夓偓鞐愳劀电� PRIME Phase 1b 鞛勳儊鞁滍棙鞚� 欤检殧 瓴瓣臣臧� 雲检潣霅╇媹雼�.
彀戈皜鞛惖鐢 鞗箘旌愳姢韸鸽 鞁滌箔頃橁卑雮� 氙戈淡 氍措鞝勴檾 888-506-0062 霕惖鐢 甑牅鞝勴檾 +1 973-528-0011鞐� 鞝戩啀 旖旊摐 289672毳� 鞛呺牓頃� 鞝勴檾搿� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 須岇偓 鞗轨偓鞚错姼鞐� 鞗愲 雿办澊韯� 氚滍憸氍戈臣 氚滍憸 鞛愲臧� 瓴岇灛霅橃柎 鞛堨姷雼堧嫟.
Revelation Biosciences (NASDAQ:REVB) rappelle son webcast et sa conf茅rence t茅l茅phonique pr茅vus le 10 septembre 脿 8h30, heure de l'Est. L'茅v茅nement pr茅sentera les donn茅es principales de l'essai clinique PRIME Phase 1b.
Les participants peuvent se joindre via le webcast ou appeler le num茅ro gratuit 888-506-0062 (脡tats-Unis) ou +1 973-528-0011 (international) avec le code d'acc猫s 289672. L'annonce initiale des donn茅es et les supports de pr茅sentation sont disponibles sur le site de la soci茅t茅.
Revelation Biosciences (NASDAQ:REVB) erinnert an den bevorstehenden Webcast und die Telefonkonferenz am 10. September um 8:30 Uhr Eastern Time. In der Veranstaltung werden die Topline-Daten der PRIME Phase 1b-Studie besprochen.
Teilnehmer k枚nnen per Webcast teilnehmen oder 眉ber die geb眉hrenfreie Nummer 888-506-0062 (USA) bzw. +1 973-528-0011 (international) mit Zugangs-Code 289672 einw盲hlen. Auf der Unternehmenswebsite sind die urspr眉ngliche Datenmitteilung und die Pr盲sentationsunterlagen verf眉gbar.
- None.
- None.
SAN DIEGO, CA / / September 9, 2025 / (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, wants to remind you of our September 10th webcast at 8:30 am Eastern Time, which can be accessed or to call in, please dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use the participant access code 289672. We look forward to reviewing the data with you tomorrow morning.
A copy of the original press release announcing data can be found .
A copy of the presentation to be reviewed can be found .
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and the treatment of chronic kidney disease.
For more information on Revelation, please visit .
Company Contact
Mike Porter
Investor Relations
Porter LaVay & Rose Inc.
Email: [email protected]
Chester Zygmont, III
Chief Financial Officer
Revelation Biosciences Inc.
Email: [email protected]
SOURCE: Revelation Biosciences, Inc.
View the original on ACCESS Newswire
FAQ
When is Revelation Biosciences (REVB) hosting its PRIME Phase 1b data webcast?
How can investors join Revelation Biosciences' PRIME Phase 1b data conference call?
What will be discussed in REVB's upcoming conference call?
Where can investors find materials for Revelation Biosciences' PRIME Phase 1b presentation?
